Healthcare Global Enterprises Ltd
NSE:HCG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Healthcare Global Enterprises Ltd
NSE:HCG
|
IN |
|
Avary Holding Shenzhen Co Ltd
SZSE:002938
|
CN |
|
S
|
Sigong Tech Co Ltd
KOSDAQ:020710
|
KR |
|
NRC Group ASA
OSE:NRC
|
NO |
|
IWG Plc
LSE:IWG
|
CH |
|
Zeria Pharmaceutical Co Ltd
TSE:4559
|
JP |
|
I
|
Impact Coatings AB (publ)
F:1IC
|
SE |
|
Suheung Co Ltd
KRX:008490
|
KR |
|
Decklar Resources Inc
XTSX:DKL
|
CA |
|
Inotiv Inc
NASDAQ:NOTV
|
US |
Wall Street
Price Targets
HCG Price Targets Summary
Healthcare Global Enterprises Ltd
According to Wall Street analysts, the average 1-year price target for
HCG
is 778.34 INR
with a low forecast of 656.48 INR and a high forecast of 939.19 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HCG's stock price target?
Price Target
778.34
INR
According to Wall Street analysts, the average 1-year price target for
HCG
is 778.34 INR
with a low forecast of 656.48 INR and a high forecast of 939.19 INR.
What is Healthcare Global Enterprises Ltd's Revenue forecast?
Projected CAGR
16%
For the last 13 years the
compound annual growth rate for
Healthcare Global Enterprises Ltd's revenue is
18%.
The projected
CAGR
for the next 3 years is
16%.
What is Healthcare Global Enterprises Ltd's Operating Income forecast?
Projected CAGR
37%
For the last 13 years the
compound annual growth rate for
Healthcare Global Enterprises Ltd's operating income is
19%.
The projected
CAGR
for the next 3 years is
37%.
What is Healthcare Global Enterprises Ltd's Net Income forecast?
Projected CAGR
77%
The
compound annual growth rate
of Healthcare Global Enterprises Ltd's net income for the next 3 years is
77%.
